![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61B 5/154 | (2006.01) |
A61B 5/15003 | (2013.01) | ||
A61B 5/15 | (2006.01) | ||
A61B 5/150755 | (2013.01) | ||
A61B 5/154 | (2013.01) | ||
B01L2200/16 | (2013.01) | ||
B01L 3/5082 | (2013.01) |
(11) | Number of the document | 3334343 |
(13) | Kind of document | T |
(96) | European patent application number | 16757774.1 |
Date of filing the European patent application | 2016-08-12 | |
(97) | Date of publication of the European application | 2018-06-20 |
(45) | Date of publication and mention of the grant of the patent | 2022-10-19 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2016/046681 |
Date | 2016-08-12 |
(87) | Number | WO 2017/027771 |
Date | 2017-02-16 |
(30) | Number | Date | Country code |
201562204644 P | 2015-08-13 | US | |
201562214308 P | 2015-09-04 | US |
(72) |
SEXTON, Daniel, J. , US
FAUCETTE, Ryan , US
|
(73) |
Takeda Pharmaceutical Company Limited ,
1-1, Doshomachi 4-chome,
Chuo-ku,, Osaka-shi, Osaka,
JP
|
(54) | EVACUATED BLOOD COLLECTION TUBES CONTAINING PROTEASE INHIBITORS FOR THE ASSESSMENT OF CONTACT SYSTEM ACTIVATION |
EVACUATED BLOOD COLLECTION TUBES CONTAINING PROTEASE INHIBITORS FOR THE ASSESSMENT OF CONTACT SYSTEM ACTIVATION |